CytoMed Therapeutics Ltd (GDTC)

CIK 1873093 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for CytoMed Therapeutics Ltd.

Recent SEC filings

FiledFormAccession number
Aug 11, 20261440001477932-26-004854
Jul 24, 202640001493152-26-034516
Jul 24, 2026SCHEDULE 13D/A0001493152-26-034520
Jul 24, 20264/A0001493152-26-034654
Jun 23, 20266-K0001493152-26-029736
Jun 15, 202640001493152-26-028589
Jun 3, 20266-K0001493152-26-027044
May 26, 202630001493152-26-025179
May 15, 202630001493152-26-023400
May 15, 202630001493152-26-023405
May 15, 20266-K0001493152-26-023342
May 15, 202630001493152-26-023401
May 15, 202630001493152-26-023399
May 15, 202630001493152-26-023404
May 13, 20261440001477932-26-003023
May 11, 20266-K0001493152-26-022134
Apr 14, 20266-K0001493152-26-016552
Mar 31, 20266-K0001493152-26-013882
Mar 31, 202620-F0001493152-26-013813
Feb 12, 20261440001477932-26-000766
Jan 28, 20266-K0001493152-26-003920
Jan 13, 20266-K0001493152-26-001950
Dec 8, 20256-K0001493152-25-026530
Nov 18, 20256-K0001493152-25-023989
Nov 6, 20256-K0001493152-25-020993